Successful infliximab treatment for refractory COVID-19-associated multisystem inflammatory syndrome in two Taiwanese children: An experience from a medical center.

Liu, Chun-Ting; Luxton, G W Gant; Sung, Chia-Cheng; Wang, Fu-Min; Chang, Chia-Ning; Hu, Chih-Fen

Liu, Chun-Ting; Luxton, G W Gant; Sung, Chia-Cheng; Wang, Fu-Min; Chang, Chia-Ning; Hu, Chih-Fen.

Affiliation

Liu CT; Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
Luxton GWG; Department of Molecular and Cellular Biology, University of California-Davis, Davis, CA, USA.
Sung CC; Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
Wang FM; Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
Chang CN; Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
Hu CF; Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC. Electronic address: caperhu@gmail.com.

Pediatr Neonatol ; 65(3): 305-307, 2024 May.

Article in En | MEDLINE | ID: mdl-38169192

Subject(s)

COVID-19; Infliximab; Systemic Inflammatory Response Syndrome; Child; Humans; COVID-19/complications; COVID-19 Drug Treatment; Infliximab/therapeutic use; SARS-CoV-2; Systemic Inflammatory Response Syndrome/drug therapy; Systemic Inflammatory Response Syndrome/etiology; Taiwan

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Systemic Inflammatory Response Syndrome / Infliximab / COVID-19 Type of study: Risk_factors_studies Limits: Child / Humans Country/Region as subject: Asia Language: En Journal: Pediatr Neonatol Year: 2024 Document type: Article Country of publication: Singapore

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google